Taiwan · Delayed Price · Currency is TWD Jia Jie Biomedical Statistics
Total Valuation
TPEX:4109 has a market cap or net worth of TWD 1.40 billion. The enterprise value is 1.01 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.01B |
Important Dates
The last earnings date was Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4109 has 118.74 million shares outstanding. The number of shares has increased by 18.72% in one year.
| Current Share Class | 118.74M |
| Shares Outstanding | 118.74M |
| Shares Change (YoY) | +18.72% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | n/a |
| Float | 92.64M |
Valuation Ratios
The trailing PE ratio is 27.44.
| PE Ratio | 27.44 |
| Forward PE | n/a |
| PS Ratio | 2.89 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 65.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 55.15, with an EV/FCF ratio of -15.68.
| EV / Earnings | 20.02 |
| EV / Sales | 2.07 |
| EV / EBITDA | 55.15 |
| EV / EBIT | n/a |
| EV / FCF | -15.68 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.36 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 3.08 |
| Debt / FCF | -0.88 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is 3.39% and return on invested capital (ROIC) is 0.05%.
| Return on Equity (ROE) | 3.39% |
| Return on Assets (ROA) | 0.03% |
| Return on Invested Capital (ROIC) | 0.05% |
| Return on Capital Employed (ROCE) | 0.04% |
| Weighted Average Cost of Capital (WACC) | 4.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.29 |
| Inventory Turnover | 12.85 |
Taxes
In the past 12 months, TPEX:4109 has paid 7.75 million in taxes.
| Income Tax | 7.75M |
| Effective Tax Rate | 12.94% |
Stock Price Statistics
The stock price has decreased by -27.61% in the last 52 weeks. The beta is 0.06, so TPEX:4109's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -27.61% |
| 50-Day Moving Average | 13.10 |
| 200-Day Moving Average | 15.08 |
| Relative Strength Index (RSI) | 27.39 |
| Average Volume (20 Days) | 194,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4109 had revenue of TWD 485.40 million and earned 50.26 million in profits. Earnings per share was 0.43.
| Revenue | 485.40M |
| Gross Profit | 150.34M |
| Operating Income | 710,000 |
| Pretax Income | 59.86M |
| Net Income | 50.26M |
| EBITDA | 15.60M |
| EBIT | 710,000 |
| Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 481.56 million in cash and 56.27 million in debt, with a net cash position of 425.29 million or 3.58 per share.
| Cash & Cash Equivalents | 481.56M |
| Total Debt | 56.27M |
| Net Cash | 425.29M |
| Net Cash Per Share | 3.58 |
| Equity (Book Value) | 1.71B |
| Book Value Per Share | 14.18 |
| Working Capital | 403.64M |
Cash Flow
In the last 12 months, operating cash flow was 21.34 million and capital expenditures -85.50 million, giving a free cash flow of -64.15 million.
| Operating Cash Flow | 21.34M |
| Capital Expenditures | -85.50M |
| Depreciation & Amortization | 14.89M |
| Net Borrowing | 47.35M |
| Free Cash Flow | -64.15M |
| FCF Per Share | -0.54 |
Margins
Gross margin is 30.97%, with operating and profit margins of 0.15% and 10.35%.
| Gross Margin | 30.97% |
| Operating Margin | 0.15% |
| Pretax Margin | 12.33% |
| Profit Margin | 10.35% |
| EBITDA Margin | 3.21% |
| EBIT Margin | 0.15% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.69%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.69% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 118.12% |
| Buyback Yield | -18.72% |
| Shareholder Yield | -17.04% |
| Earnings Yield | 3.59% |
| FCF Yield | -4.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2019. It was a reverse split with a ratio of 0.8487883546.
| Last Split Date | Mar 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.8487883546 |
Scores
TPEX:4109 has an Altman Z-Score of 7.52 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.52 |
| Piotroski F-Score | 5 |